L Belloli
Overview
Explore the profile of L Belloli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mindlin I, Herzog R, Belloli L, Manasova D, Monge-Asensio M, Vohryzek J, et al.
Commun Biol
. 2024 Sep;
7(1):1176.
PMID: 39300281
Disorders of consciousness (DoC) represent a challenging and complex group of neurological conditions characterised by profound disturbances in consciousness. The current range of treatments for DoC is limited. This has...
2.
Rohaut B, Calligaris C, Hermann B, Perez P, Faugeras F, Raimondo F, et al.
Nat Med
. 2024 May;
30(8):2349-2355.
PMID: 38816609
Accurately predicting functional outcomes for unresponsive patients with acute brain injury is a medical, scientific and ethical challenge. This prospective study assesses how a multimodal approach combining various numbers of...
3.
Willacker L, Raiser T, Bassi M, Bender A, Comanducci A, Rosanova M, et al.
BMC Neurol
. 2022 Dec;
22(1):468.
PMID: 36494776
Background: Disorders of consciousness (DoC) are severe neurological conditions in which consciousness is impaired to various degrees. They are caused by injury or malfunction of neural systems regulating arousal and...
4.
Belloli L, Cugno M, DAgostino M, Ughi N, Tedeschi A, Respizzi S, et al.
Rheumatol Int
. 2011 Dec;
33(4):1099-100.
PMID: 22198691
No abstract available.
5.
Marasini B, Conciato L, Belloli L, Massarotti M
Int J Immunopathol Pharmacol
. 2009 Oct;
22(3):573-8.
PMID: 19822074
To review recent advances and current controversies on the association between systemic sclerosis (SSc) and cancer, PUBMED was searched from 1966 to the present using the terms: systemic sclerosis, cancer,...
6.
Belloli L, Carlo-Stella N, Ciocia G, Chiti A, Massarotti M, Marasini B
Rheumatology (Oxford)
. 2008 May;
47(7):1070-2.
PMID: 18503091
Objective: To identify clinical and/or laboratory characteristics that could be risk factors for myocardial microvascular involvement in patients with SSc. Methods: Twenty-one SSc patients, clinically silent for cardiovascular disease, were...
7.
Marasini B, Belloli L, Massarotti M
Int J Immunopathol Pharmacol
. 2007 Jul;
20(2):223-8.
PMID: 17624235
Interstitial lung disease is an early and serious complication of systemic sclerosis (SSc). Because it may be asymptomatic for a long period, and only the early flogistic phase is at...